Equine Atg
Disease Related To Solid Organ Transplantation
University Hospital, ToulouseUNKNOWNPhase 4 / ApprovedDormant
BB
66/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 51/ 100
- Competitive Position
- 95/ 100
Competitive context
18 Active assets in the Disease Related To Solid Organ Transplantation cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Tacrolimus The Second Hospital of Tangshan | Phase 4 | BBB |
Angiotensin Ii University of California, San Francisco | Phase 4 | BBB |
Everolimus Novartis Pharmaceuticals | Phase 3 | BB |
Noradrenaline University of California, Los Angeles | Phase 4 | BB |
Semaglutide University Health Network, Toronto | Phase 4 | BB |
View all 34 →
Same molecule, other indications
Equine Atg is also rated in:
disease related to hematopoietic stem cell transplantActive
BB
Indicative · Phase 3
68 / 100
View asset →Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →